Latest News

ASRS 2024: Adverum Biotechnologies shares findings on Ixo-vec for wet AMD from LUNA Phase 2 trial
ASRS 2024: Adverum Biotechnologies shares findings on Ixo-vec for wet AMD from LUNA Phase 2 trial

July 17th 2024

Adverum CEO Laurent Fischer spoke exclusively to Modern Retina about the 26-week interim analysis.

Aflibercept subgroup performance in the phase 2/3 photon trial through week 48
Aflibercept subgroup performance in the phase 2/3 photon trial through week 48

July 17th 2024

ASRS 2024: What are attendees looking forward to at the conference
ASRS 2024: What are attendees looking forward to at the conference

July 17th 2024

ASRS 2024: Differential Artery-Vein Analysis Improves OCTA Performance for AI Classification of DR
ASRS 2024: Differential Artery-Vein Analysis Improves OCTA Performance for AI Classification of DR

July 17th 2024

Study suggests JAK inhibitors may reduce AMD risk in autoimmune disease patients
Study suggests JAK inhibitors may reduce AMD risk in autoimmune disease patients

July 16th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.